My SciELO
Custom servicesServices on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Cited by Google 
Similars in
SciELO 
Similars in Google
Share
Permalink
Sanidad Militar
Print version ISSN 1887-8571
Abstract
TABAKOV, A.; APARICIO HERNANDEZ, R.; PEREZ MORAN, M.J. and PRATS OLIVAN, P.. Possitive assesment of drugs: September, October and November 2014. Sanid. Mil. [online]. 2015, vol.71, n.1, pp.35-43. ISSN 1887-8571. https://dx.doi.org/10.4321/S1887-85712015000100007.
The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency made public in September, October and November of 2014, and considered of interest to the healthcare profesional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Keywords : Afamelanotida; Scenesse®; Apremilast; Aotezla®; Balugrastim; Egranli®; Darunavir/Cobicistat; Rezolsta®; Dasabuvir Sódico; Exviera®; Dulaglutida Trulicity®; Eliglustat; Cerdelga®; Estrógenos Conjugados/Bazedoxifeno; Duavive®; Ketoconazol; Ketoconazol Hra Pharma®; Naloxegol; Moventig®; Nintedanib; Vargatef®; Ofev®; Nonacog Gamma; Rixubis®; Olaparib; Lynparza®; Ombitasvir/Paritaprevir/Ritonavir; Viekirax®; Ospemifeno; Senshio®; Ramucirumab; Cyramza®; Secukinumab; Consentyx®; Sofosbuvir/Ledipasvir; Harvoni®; Tilmanocept; Lymphoseek®; Vorapaxar; Zontivity®.
